Hepatitis B chronic infection among pregnant women attending the antenatal care in Bor State Referral Hospital, South Sudan

Introduction: Hepatitis B virus (HBV) is a major public health problem affecting 400 million people worldwide, and is a common cause of chronic liver failure (cirrhosis) and hepatocellular carcinoma. Sixty-eight percent of infected people are from the African and Pacific regions. Vertical transmission from mother to newborn baby is one of the mechanisms by which chronic hepatitis virus infection spreads, besides infections from contaminated needles and syringes and sexual contact. Hepatitis B chronic infection is endemic in many poor countries, especially in Africa. Method: A cross-sectional study was conducted between July and August 2021. Pregnant women attending the antenatal care (ANC) in Bor State referral hospital, South Sudan, were interviewed to collect information on their socio-demographic characteristics and risk factors for hepatitis B infection. The objective was to determine the seroprevalence of hepatitis B chronic infection through blood testing. Prevalence ratios for certain risk factors were calculated. Results: Two hundred pregnant women were enrolled. The Prevalence Rate for chronic infection with hepatitis B virus, diagnosed using the rapid immune-chromatographic assay for Hepatitis B surface antigen (HBsAg), was 8.5%. (95% CI; 4.7% - 12.3%). None of the suspected risk factors studied were found to be significantly associated with testing positive for HBV, except for a history of previous jaundice. Conclusion: The prevalence of HBV chronic infection among pregnant women in Bor, Jonglei State, is high hence there is a need for established public health interventions that can lead to a reduction of HBV vertical transmission. Treatment of pregnant women with HBV chronic infection using anti-viral medications during pregnancy might curb the vertical transmission rates.

Seroprevalence and associated risk factors for hepatitis B virus among pregnant women attending health facility in Osogbo, Nigeria

Background Hepatitis B virus (HBV) infection among pregnant women has a high rate of vertical transmission and consequential effects on fetal and neonatal outcomes. The aim of this study was to determine the prevalence and associated risk factors of infection among pregnant women attending antenatal care services in Osogbo, Nigeria. Methodology This hospital based cross-sectional study was conducted among pregnant women attending routine antenatal care clinic between April and June 2021. Systematic random sampling technique was used to recruit 240 pregnant women, their data were collected by face to face interview using a pretested questionnaire, while blood sample was collected aseptically to determine hepatitis B surface antigen by enzyme linked immunosorbent assay test kit. Univariate and multivariate logistic regression were used to examine the association between explanatory variables and outcome variable. Results The mean age and seroprevalence of the study population were 27.50 ± 4.4 years and 5.8% respectively. The significant risk factors for HBV infection were tattooing (aOR = 5.22; 95% CI = 0.52­8.01; p = 0.0000), history of multiple sexual partners (aOR = 2.88; 95% CI = 1.92­12.42; p = 0.0044); and past history of contact with HBV patient (aOR = 2.17; 95% CI = 1.21­15.32; p = 0.0310) were significant predictors of HBV infection. Conclusion The seroprevalence of HBV from this study was of intermediate endemicity. We therefore, advocate for continuous health education programs on the mode of HBV transmission, high-risk behaviors and methods of preventions at antenatal care clinics to raise the awareness of mothers and limit the spread of infection.

Prévalence de l'infection par l'hépatite virale B et facteurs associés chez les enfants des sujets ivoiriens porteurs de l'AGHBS / Prevalence of hepatitis B infection and factors associated in children of Ivorian HBsAg carrier

Objectifs : Déterminer la prévalence de l'infection par le virus de l'hépatite B (VHB) chez les enfants (sujets contact) des sujets porteurs chroniques de l'Ag HBs (sujets index) et rechercher les facteurs associés à cette infection chez ces enfants.Patients et méthodes: il s'est agi d'étude rétrospective transversale portant sur les patients positifs pour l'Ag HBs (sujets index), dont la famille (sujets contact: conjoints et enfants) a été soumise à un dépistage systématique de l'infection par le VHB. Résultats: L'âge médian de nos 44 sujets était de 43,1 ± 7,49 ans. Le nombre moyen d'enfants par sujet index était de 2,3 ± 1,1. L'âge médian des 92 enfants était de 9,3 ± 4,55 (de 1 à 15 ans) et 43 (44,8%) étaient vaccinés contre le VHB. La fréquence de l'infection par le VHB était de 24%. Les facteurs indépendants associés à l'infection par le VHB chez les enfants étaient l'ADN du VHB pour les sujets index> 2000 UI/ml (OR = 11,5; p = 0,001), l'existence du VHB chez les deux parents (OR = 7,9; p = 0,03) et l'absence de vaccination contre le VHB chez les enfants (OR = 30,9; p = 0,003). Conclusion: La couverture vaccinale des enfants des sujets index était insuffisante. Outre la transmission verticale, le risque de transmission intrafamiliale était élevé en présence d'au moins un des trois facteurs associés

Objectives: To determine the prevalence of hepatitis B virus (HBV) infection in children (contact subjects) of chronic HBsAg (index subjects) and to investigate the factors associated with this infection in these children. Patients and methods: this was a retrospective cross-sectional study of HBsAg positive patients (index subjects), whose families (contact subjects: spouses and children) were routinely screened for HBV infection. Results: The median age of our 44 subjects was 43.1 ± 7.49 years. The average number of children per index subject was 2.3 ± 1.1. The median age of the 92 children was 9.3± 4.55 (1 to 15 years) and 43 (44.8%) were vaccinated against HBV. The prevalence of HBV infection was 24%. The independent factors associated with HBV infection in children were HBV DNA for index subjects> 2000 IU/ml (OR = 11.5; p = 0.001), the existence of HBV in both parents (OR = 7.9; p = 0.03) and no HBV vaccination in children (OR = 30.9; p = 0.003). Conclusion: Immunization coverage of children of index subjects was insufficient. In addition to vertical transmission, the risk of intrafamilial transmission was high in the presence of at least one of the three associated factors.

Epidemiology of hepatitis B virus infection among pregnant women in Lubumbashi, Democratic Republic of Congo: prevalence, risk factors, and genotype distribution

Background Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) is a significant public health problem. Most children under five years living with HBV in endemic areas like sub-Slivingan Africa. Vertical transmission is considered the main newborn's route of contamination, which leads in 90% of cases to the chronic stage of the disease. Objectives To determine the seroprevalence and identify risk factors of carrying hepatitis B surface Antigen (HBsAg) in pregnant women, assess biochemical parameters, and study the distribution of HBV genotypes among infected pregnant women in Lubumbashi. Methods This was a cross-sectional descriptive and experimental study in which 1711 pregnant women were recruited. The study took place in the hospital Jason Sendwe of Lubumbashi. A pre-established epidemiological survey form was used to collect data from the study population. Results The seroprevalence of HBV among pregnant women was 4.4%. Blood transfusion and unprotected sex have been associated with the risk of carrying HBsAg. Increased levels of bilirubin and transaminases were observed. The genotypes E (59.4%), A (40.6%), and a few drug resistance mutations were identified in the study population. Conclusion With an HBV seroprevalence of 4.4%, MTCT of HBV remains a public health concern in Lubumbashi. This result highlights the vital role of HBV screening in pregnant women and newborns and early HBV vaccination. In addition, the obtained HBV genotyping data could help better understand the local epidemiology of the disease, predict the outcome of the Antiviral therapy, and develop a mapping of HBV genotypes in Lubumbashi.

Sero-prevalence of Hepatitis B virus surface antigen and associated factors among women of reproductive age in Bench Maji Zone, Southwest Ethiopia: community based cross-sectional study

Background: Hepatitis B virus infection is one of the leading causes of liver diseases which occurs worldwide particularly in developing countries. It is often caused by prenatal transmission from mother to child or household transmission from a close contact during early childhood. It causes different complications like; jaundice, induces premature labor, and prematurity. Objective: The aim of this study was to estimate the sero-prevalence of hepatitis B virus surface antigen and associated factors among women of reproductive age in Bench Maji Zone, South West Ethiopia. Methods: A community-based cross-sectional study was conducted from December 15th, 2016 to February 15th, 2017. Multistage sampling technique was applied to select study participants. Logistic regression analysis was applied and p-values < 0.05 was used to see the significant association between dependent and independent variables. Results: A total of 330 participants were included in this study yielding 98.8% response rate. The sero-prevalence of HBsAg among women of reproductive age was 28(8.5%). Having multiple sexual partners (AOR = 18.73, 95% CI =3.65, 96.21) history of unprotected sex (AOR = 9.39, 95% CI =1.64, 53.77) were found to be significantly associated with sero-prevalence of HBV. Conclusions: The sero-prevalence of HBV infection among women of reproductive age was highly endemic. Hence, behavioral education and communication programs focusing on reduction of risky sexual behaviors should be designed to reduce HBV infection.

Seroprevalence of Hepatitis B virus infection and associated factors among mothers in gondar, North-West Ethiopia: a population based study

Background: Hepatitis B virus (HBV) is the main cause of serious liver infection. Factors that increase the risk of HBV infection include contact during child birth and different horizontal means of transmission, such as unprotected sexual exposure with an infected person and having direct contact with the blood of an infected person. Objectives: The main aim of this study is to determine seroprevalence of HBV infection and associated risk factors among mothers in Gondar, Northwest Ethiopia. Methods: A community based cross-sectional study was conducted on mothers in Gondar from March to November 2016. Study participants were selected using a multistage cluster random sampling technique and a total of 419 mothers were included. Sociodemographic data and exposure to associated factors (hospital admission, history of circumcision, history of contact with jaundiced family and history of abortion) were collected through a structured questionnaire. Five milliliters of blood were collected from each study participant. Serum level hepatitis B surface antigen (HBsAg) and anti-HBc were detected using sandwich and indirect ELISA, respectively. The data were entered with Epi Info 7 and analyzed using SPSS version 20. To declare the presence of association, odds ratio with 95% confidence interval and p-value <0.05 were considered statistically significant. Result: A total of 419 mothers with the median age of 29 (20-58) years old were enrolled. The sero-prevalence of HBsAg and anti-HBc was 3.8% and 36.0%, respectively. Statistically significant association with HBV infection was observed for age (AOR= 6.960, 96% CI, 2.047-23.659, P= 0.002), history of hospital admission (AOR= 3.279, 95% CI, 1.054-10.195, P= 0.04), history of circumcision (AOR= 4.394, 95% CI, 1.463-13.198, P= 0.008), history of contact with jaundiced family (AOR= 3.877, 95% CI, 1.274-11.795, P= 0.017) and history of abortion (AOR= 4.867, 95% CI, 1.438-16.473, P= 0.011). Conclusions and recommendations: An intermediate seroprevalence of HBV infection, which is an important public health problem in the area, was detected. Therefore, implementing strategies for routine screening and care of mothers for hepatitis B virus would be important. Further, health education on modes of transmission and precautions and immunization of HBV has to be strengthened

Prevalence and associated risk factors of Hepatitis B and C virus infections among mothers in Jimma, South West Ethiopia: a community-based study

Background: Viral hepatitis affects over 400 million people globally with 6 to 10 million people newly infected each year. Viral hepatitis infectious agents such as hepatitis B virus (HBV) and hepatitis C virus (HCV) are among the greatest threats to the liver and can cause liver cancer. One of the most important modes of transmission of these viruses is a vertical transmission from mother to child. The aim of this study is to assess the prevalence of HBV and HCV infection as well as its associated risk factors among mothers in Jimma. Methods: A community-based cross-sectional study was conducted among 455 mothers in Jimma from June to December 2016. Simple random sampling was employed to recruit study participants and informed consent was obtained. From each mother, about 5ml of blood was collected and tested for HBsAg, anti-HBc, and HCVAg/Ab using ELISA. Chi-square and logistic regression tests were used to assess statistically significant associations between dependent and independent variables. P-values less than 0.05 were considered statistically significant. Result: HBsAg, anti-HBc and HCVAg/Ab prevalence was 5.7%, 30.5% and 2.5%, respectively. Multivariate logis-ic regression analysis showed that history of hospital admission (AOR = 3.098; P <0.040) and abortion (AOR = 15.514, P <0.001) remained independent predictors of HBsAg seropositivity. Conclusion: Hospital admission and abortion are the major risk factors for hepatitis B and C virus infection among mothers. Awareness creation for adult HBV vaccine and health education on modes of transmission should be promoted and strengthened

Antibody response against Hepatitis B virus after vaccination and seroprevalence of HBV in children in Addis Ababa, Ethiopia

Background: Around two billion people have been infected with HBV worldwide, and more than 240 million are chronic carriers. Vaccine introduction for HBV in children was officially launched by the WHO in 1980. Since then the vaccine response level has been determined in different countries. Since the introduction of the vaccine in Ethiopia in 2007, few studies have been conducted to assess the antibody response against the HBV vaccine. Objectives: The aim of this study is to determine antibody response against HBV after hepatitis B vaccination and assess the seroprevalence of HBV in children in Addis Ababa, Ethiopia. Methods: A cross-sectional study was conducted using a multistage probability sampling technique. Four hundred and fifty children between the ages of 5 and 8 living in Addis Ababa were enrolled. Socio-demographic characteristics were obtained through a structured questionnaire and three to four ml of blood was collected from each child. ELISA was performed to determine antibody levels against HBV. Results:The mean age was 7+1 (SD) years. Anti-HBs were detected in 54.3% (208/450) of children with a slightly higher proportion of protective level in females 98 (54.7%) than males 110 (53.9%). The overall vaccine coverage in our study was 85.1 %. The proportion of children with a protective level (>10 mIU/ml anti-HBs antibody) declined as the age of the child increased: 52.6%, 60%, 43.5% and 37.1% at the age of 5, 6, 7 and 8 years, respectively. Seroprevalence of HBsAg was 0.4%, whereas seroprevalence of anti-HBc was 5.6%. Age was negatively correlated with the response level (p=0.001), whereas sex and history of HBV infection had no significant association. Age was also significantly associated with seroprevalence of anti-HBc (p=0.003). Conclusion: The HBV vaccine coverage in children was high but antibody response against the vaccine appears low. Seroprevalence of the virus was also low. The low response level to the vaccine should be a concern and revaccination or booster doses should be considered for non-responding children. Further studies should also be undertaken

Preliminary study of seroprevalence and risk factors for hepatitis B infection in pregnant women in Lubumbashi, Democratic Republic of the Congo

Background: Hepatitis B virus (HBV) infection, defined as positivity for hepatitis B surface antigen (HBsAg), remains a public health problem nationally and globally. The objective of this study was to determine the seroprevalence and risk factors for HBV infection in pregnant women in the city of Lubumbashi.Methods: A Cross-sectional study of the 269 pregnant women received at Shalina Polyclinic in Lubumbashi was conducted. HBV screening was performed by the PCR technique (using the COBAS TaqMan 48 controller). The chi-square test and the calculation of the odds-ratios with 95% Confidence Intervals were used with the significance level set at p less than 0.05.Results: The mean age of pregnant women was 30.0 ± 5.34 years (range, 17 to 44 years). The majority of them were unemployed (98.51%) and married (99.25%). All pregnant women were unaware of their HBV serologic status and had not been vaccinated against HBV. Eighteen (6.69% [95% CI: 4.01-10.37%]) participants had HBsAg positive and four (1.48% [95% CI: 0.41-3.76%]) were HIV-positive. The highest prevalence of hepatitis B was observed in the age group between 31-40 (10.53%), single (50%), women with paying occupation (25%) and diabetes mellitus (14.29%) and a history of surgery (14.29%) with no statistically significant difference (p>0.05). However, HBV was significantly higher in HIV-positive pregnant women, who presented a risk of nearly 9-fold higher (50% versus 6.04%; OR adjusted: 8.89 [1.04-76.09]) compared to HIV-negative pregnant women.Conclusion: our study shows that hepatitis B is a public health problem among pregnant women in the city of Lubumbashi. The history of HIV infection is independently associated with HBV infection in this context

Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns

The low rate of screening for hepatitis B virus (HBV) in pregnant women is a highrisk factor for its vertical transmission. The objectives of this study were: i) to screen pregnant women for HBV infection; ii) vaccinate all children from birth against HBV regardless their mother HBV status; and iii) evaluate after 7 months of birth the level of their AbHBs among babies who received HBV vaccine at birth. Serological markers of HBV (HBsAg, HBeAg, AbHBs, AbHBe, and AbHBc) were determined on venous blood samples from 237 pregnant women and their children using the Abon Biopharm Kit. One hundred and two (102) children received the three doses of the EUVAX B® vaccine respectively at birth, two months and four months of life. Seven months after delivery, venous blood samples were collected from mothers and their children. Antibodies against hepatitis B surface antigen (AbHBs) were measured in vaccinated children using the ELISA Kit AbHBs Quantitative EIA. DNA extraction was performed on samples from HBV-seropositive mothers and their children using the Ribo Virus (HBV Real-TM Qual) Kit and for Real Time PCR, the HBV Real-TM Qual Kit was used. Serological diagnosis in pregnant women revealed 22 (9.28%) hepatitis B surface antigen (HBsAg) positive samples of which 21 were positive for viral DNA by real-time PCR. Among the 22 HBsAg+ women, five (05) transmitted the virus to their children with a vertical transmission rate of 22.73%. A transmission rate of 23.81% (5/21) was found with the PCR method. Analysis of AbHBs levels revealed that 98.31% of the children had an average concentration of 218.07 ± 74.66 IU/L, which is well above the minimum threshold for protection (11 IU/L). This study has confirmed that vertical transmission of HBV is a reality in Burkina Faso and that vaccination at birth would significantly reduce this transmission

The status of hepatitis B control in the African region

The World Health Organization (WHO) African Region has approximately 100 million people with chronic hepatitis B virus (HBV) infection. This review describes the status of hepatitis B control in the Region. We present hepatitis B vaccine (HepB) coverage data and from available data in the published literature, the impact of HepB vaccination on hepatitis B surface antigen (HBsAg) prevalence, a marker of chronic infection, among children, HBsAg prevalence in pregnant women, and risk of perinatal transmission. Lastly, we describe challenges with HepB birth dose (HepB-BD) introduction reported in the Region, and propose strategies to increase coverage. In 2015, regional three dose HepB coverage was 76%, and 16(34%) of 47 countries reported ≥ 90% coverage. Overall, 11 countries introduced HepB-BD; only nine provide universal HepB-BD, and of these, five reported ≥ 80% coverage. From non-nationally representative serosurveys among children, HBsAg prevalence was lower among children born after HepB introduction compared to those born before HepB introduction. However, some studies still found HBsAg prevalence to be above 2%. From limited surveys among pregnant women, the median HBsAg prevalence varied by country, ranging from 1.9% (Madagascar) to 16.1% (Niger); hepatitis B e antigen (HBeAg) prevalence among HBsAg-positive women ranged from 3.3% (Zimbabwe) to 28.5% (Nigeria). Studies in three countries indicated that the risk of perinatal HBV transmission was associated with HBeAg expression or high HBV DNA viral load. Major challenges for timely HepB-BD administration were poor knowledge of or lack of national HepB-BD vaccination guidelines, high prevalence of home births, and unreliable vaccine supply. Overall, substantial progress has been made in the region. However, countries need to improve HepB3 coverage and some countries might need to consider introducing the HepB-BD to help achieve the regional hepatitis B control goal of < 2% HBsAg prevalence among children < 5 years old by 2020. To facilitate HepB-BD introduction and improve timely coverage, strategies are needed to reach both facility-based and home births. Strong political commitment, clear policy recommendations and staff training on HepB-BD administration are also required. Furthermore, high quality nationally representative serosurveys among children are needed to inform decision makers about progress towards the regional control goal

Studies on Prevalence and Risk Factors for Hepatitis B Surface Antigen among Secondary School Students in North-Central; Nigeria

Hepatitis B virus (HBV) Infection is one of the major global public health problems; with its attendant risks especially among the young adults. This study was therefore carried out to assess the sero-prevalence of hepatitis B surface antigen (HBsAg) and associated risk factors among students of a secondary school in Jagindi Tasha; Kaduna State; Nigeria. One hundred and ninety (190) apparently healthy students were screened and sera samples obtained were separated and analysed for HBsAg using a commercially available Enzyme Linked Immunosorbent Assay (ELISA)-based kit (Dialab). Information was obtained for risk factors using structured questionnaire. Out of the 190 samples screened; 35 (18.4) were sero-positive. Subjects aged 13-15 years recorded 6.8 positivity (x2 = 1.084; p0.05) and male subjects had 25.5 positivity compared to 10.9 positivity for females (x2 = 6.768; p0.05). Risk factors such as blood transfusion was 32.0 among male subjects compared to 30.0 in females (x2

Seroprevalence of human immunodeficiency and hepatitis b viruses among patients at a health facility in Freetown; Sierra Leone

Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) constitute serious public health problems worldwide. In Sierra Leone; information on both viral infections remains scanty. This study estimated the seroprevalence of HIV and HBV infections and a possible co-infection in one hundred and ninety-eight (198) patients seeking diagnosis at a private laboratory in Freetown; Sierra Leone. Blood plasma was collected from each patient after informed consent was obtained. The samples were assayed for antibodies to HIV virus and HBV antigen using appropriate assays. Male patient accounts for 52of the population examined. Thirty-one (31) of the 198 patients examined (15.7) were positive for HIV. Hepatitis B surface antigen (HbsAg) was present in 17 (39.5) females and 26 (60.5) males. Thirteen (13) (6.6) patients were co-infected with HIV and HBsAg. This is the first documented evidence of HBsAg and HIV co-infection in Sierra Leoneans. Larger population based studies are however needed to confirm the findings

Seroprevalence of Hepatitis B Surface Antigen (HBsAg) among Children of Primary School Age in a Community; North-Central; Nigeria

Globally; Hepatitis B Virus has been identified as one of the most common infectious diseases and a major public health problem.This study was therefore carried out to assess the prevalence of Hepatitis B virus infection among primary school children attending LGE primary school; Sabon Pegi; Kuru; Nigeria. Three hundred and sixty (360) blood samples were collected from the pupils and sera separated and analyzed for HBsAg using one step Hepatitis B surface antigen test strip. Of the 360 samples screened; 35 (9.7) were sero-positive. Pupils within the age 7-9 years had the highest prevalence of 3.9. Male subjects recorded a prevalence of 6.1compared to 3.6for females. Risk factors such as blood transfusion recorded 1.6. Furthermore; family history of HBV infection accounted for 3.6; while male subjects that had traditional method of circumcision recorded a high prevalence of 3.3. Unfortunately; the prevalence of this ravaging infectious agent appears to be high amongst the subjects studied. It is strongly suggested that public awareness be accorded urgent attention while socioeconomic development in these areas be given priority as a measure to preventing further spread of this virus amongst children; particularly the school age group

Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey

Background: Infant immunization against hepatitis B began in Uganda in 2002. Objective: To determine the baseline prevalence of hepatitis B virus (HBV) infection and explore risk factors. Methods: A hepatitis B prevalence study was nested in the 2005 national HIV/AIDS serobehavioural survey. Demographic characteristics and risk factors were explored by questionnaire. One third of blood specimens (n=5875) from adults aged 15 to 59 years were tested for hepatitis B core antibodies (HBcAb); positive specimens were tested for hepatitis B surface antigen (HBsAg). Results: HBcAb was present in 52.3(95CI: 51.0-53.6) of adults; and HBsAg in 10.3(9.5-11.1). By 15-19 years of age; 40.0had been infected with HBV. Prevalence of both markers was significantly higher across northern Uganda; in rural areas; among the poor and least educated; and in uncircumcised men. Other independent predictors of infection were age; ethnic group; occupation; number of sex partners; and HIV and HSV-2 status. Conclusion: Hepatitis B virus infection is highly endemic in Uganda; with transmission occurring in childhood and adulthood. More than 1.4 million adults are chronically infected and some communities disproportionately affected. The hepatitis B infant immunization programme should be sustained and catch-up vaccination considered for older children

Sero-Prevalence of Hepatitis B Surface Antigen among Individuals with HIV - Related Cutaneous Disorders at a Tertiary Referral Dermatology Clinic in Dar es Salaam

Background: HIV and hepatitis B virus (HBV) infections are common in sub Saharan Africa. HIV/AIDS is associated with a wide variety of cutaneous disorders which herald the onset of severe immunosuppression. In sub Saharan Africa; HBV is transmitted mainly horizontally through skin contact. Few studies if any have determined the prevalence of HBV infection among HIV sero-positive individuals with HIV - related cutaneous disorders. Objective: To determine the sero - prevalence of hepatitis B surface antigen among HIV - seropositive individuals with HIV- related cutaneous disorders.Setting: Tertiary referral Dermatology clinic; Muhimbili National Hospital; Dar es Salaam.Design and methods: Hospital based controlled study whereby consecutive patients with HIV - related cutaneous disorders were enrolled. After filling in a questionnaire and undergoing dermatological examination blood was drawn for HBsAg and HIV antibody screening. Adult and secondary school student blood donors were used as controls.Results: 384 patients with HIV-related skin lesions were enrolled into the study. 354 (92

Prevalence of Hepatocellular Carcinoma; liver Cirrhosis and HBV Carriers in Liver Disease Patients Reffered to Clinical Research Centre; Kemri

The prevalence of HBsAg positivity; liver cirrhosis (LC) and hepatocellular carcinoma (HCC) is studied in 139 patients at the Clinical Research Centre of KEMRI. The prevalences were found to be 15.1; 9.3and 10respectively. 14of the HBsAg positives were also E antigen positive. The positivity of HBsAg in HCC was 42.9only 15.4in LC and 57.1HCC had AFP compared to only 15.4in LC. It is suggested that the findings support an association of Hepatitis B virus with LC and HCC